Press Release
August 02, 2023
Icon Genetics receives eu patent for its invention on norovirus-like particles with increased stability
continue reading
Press Release
June 26, 2023
Icon Genetics has published a second milestone paper further detailing the remarkable immune responses elicited by the novel norovirus vaccine candidate in a successfully completed phase i clinical study
continue reading
Press Release
October 07, 2022
Icon Genetics has published a first milestone paper about the successfully completed phase i clinical study of a novel norovirus vaccine
continue reading
Press Release
February 11, 2022
Icon Genetics has published a milestone paper about the successfully completed pre-clinical evaluation of a novel norovirus vaccine candidate
continue reading
Press Release
October 02, 2020
Icon Genetics clinical development of its novel norovirus vaccine reaches milestone of complete dosing of the first cohort
continue reading
Press Release
September 23, 2020
DENKA press release: Phase I Clinical Study to Develop a Norovirus Vaccine Commenced in Belgium
continue reading
Press Release
March 11, 2020
A new investment in Sachsen-Anhalt is announced to build a pilot facility to support healthcare related research & development and the manufacturing of proteins for diagnostic use.
continue reading
Press Release
August 23, 2017
Denka Completes the Acquisition of Icon Genetics GmbH, a German Bio-Pharmaceutical R&D Company, Making It a Wholly Owned Subsidiary
continue reading
Press Release
August 07, 2015
Announcement of Acquisition of Shares (Ownership) in Icon Genetics GmbH, a German Bio-pharmaceutical R&D Company
continue reading